Fluorescent squaramides as anion receptors and transmembrane anion transporters by Bao, Xiaoping et al.
Journal Name  
COMMUNICATION 
This journal is © The Royal Society of Chemistry 20xx J. Name .,  2013, 00 , 1-3 | 1   
Please do not adjust margins 
Please do not adjust margins 
a. Chemistry, University of Southampton, Southampton, SO17 1BJ, UK 
b. State Key Laboratory Breeding Base of Green Pesticide and Agricultural 
Bioengineering, Key Laboratory of Green Pesticide and Agricultural 
Bioengineering, Ministry of Education, Center for Research and Development of 
Fine Chemicals, Guizhou University, Guiyang 550025, China 
c. School of Chemistry, The University of Sydney, NSW 2006, Australia. E-mail: 
philip.gale@sydney.edu.au 
d. Singapore Bioimaging Consortium, Agency for Science, Technology and Research 
(A*STAR), Singapore 138667, Singapore 
e. Center for Self-assembly and Complexity, Institute for Basic Science (IBS), Pohang 
37673, Republic of Korea 
f. Department of Chemistry, Pohang University of Science and Technology 
(POSTECH), Pohang 37673, Republic of Korea. 
Electronic Supplementary Information (ESI) available: Compounds synthesis, NMR 
binding studies, fluorescent titrations, membrane transport studies, and 
fluorescent imaging in cells. See DOI: 10.1039/x0xx00000x 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
Fluorescent squaramides as anion receptors and transmembrane 
anion transporters  
Xiaoping Bao,ab Xin Wu,c Stuart N. Berry,acd Ethan N. W. Howe,c Young-Tae Chang,e,f and Philip A. 
Gale*c
A series of squaramide-based anion transporters functionalised 
with the 1,8-naphthalimide fluorophore has been developed for 
improved ionophoric activity and fluorescent imaging in cells. 
The transport of chloride ions across cell membranes is an 
important physiological process, which regulates intra- and 
extracellular pH, membrane potential, and cellular volume that 
are crucial to many biological processes including cell 
migration, proliferation and differentiation.1 Intracellular 
chloride concentrations are regulated by naturally occurring 
anion channels in biological systems. A number of diseases, 
including cystic fibrosis (CF), involve malfunctioning ion 
channels (these diseases are collectively known as 
channelopathies).2 Development of small molecule synthetic 
anion transporters (anionophores)3 capable of restoring 
chloride permeability across lipid bilayers has been proposed 
as a new approach to treating this class of disease.4 In 
addition, anionophores have been reported to alter pH and 
ionic gradients between intracellular and extracelluar 
compartments, which may lead to cytotoxicity, affording the 
possibility to use these anionophores as anticancer agents.5 
Our group have previously reported fluorescent anion 
transporters based on naphthalimide-(thio)urea conjugates 
and demonstrated their potential in studying the partitioning, 
localization and action of these fluorescent anionophores 
within living cells using fluorescence imaging techniques.6 
Those compounds, however, show modest anion transport 
efficacy compared with our most active transporters.7 To 
improve the anion transport rate potentially allowing the use 
of fluorescent transporters at lower doses, we have decided to 
use the squaramide instead of the (thio)urea as the anion 
binding site and functionalise it with a 1,8-naphthalimide 
fluorophore.8 Compared with the most extensively-utilized 
urea and thiourea groups for anion complexation, the 
squaramide group confers the advantage of enhanced anion-
binding affinities9 which has been shown to benefit anion 
transport efficacy.10 Herein we report the synthesis of four 
novel fluorescent squaramide-based anion transporters 1-4 
(Fig. 1) and studied their anion binding and transmembrane 
transport properties as well as their live-cell imaging 
capabilities. 
 
Fig. 1 Structures of compounds 1-4. 
Compounds 1-4 were readily obtained by reaction of 4-(4-
aminobutylamino)-1,8-naphthalimide with squarate 
monoesters  (see ESI for synthetic details and characterization 
data). Single crystals of compound 4 suitable for X-ray 
diffraction analysis were obtained by slow evaporation of a 
DMSO solution of 4 at room temperature. The crystal structure 
(Fig. 2) showed that compound 4 formed a 1:1 complex with 
DMSO via two squaramide NH×××O hydrogen bonds (N×××O 
distances of 2.834(2) and 2.821(3) Å and N-H×××O bond angles 
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of 163.3o and 155.1o, respectively). The 4-amino NH group of 
the naphthalimide moiety was not involved in the hydrogen 
bonding interaction with the DMSO solvate, despite the 
presence of a flexible 1,4-butylene linker between the 
naphthalimide and squaramide moieties.  
 
Fig. 2 Crystal structure of 1·DMSO complex (CCDC 1530149). 
The binding affinities of compounds 1-4 for chloride (as tetra-
n-butylammonium salt) were evaluated via 1H NMR titrations 
in DMSO-d6 (ESI). For compound 1 upon the addition of Cl-, 
significant downfield shifts were observed for the two 
squaramide NHs (Dd > 1.3 ppm) as well as two aromatic CH 
protons from the 3,5-di-CF3-Ph group (Dd = +0.22 ppm). In 
contrast, the naphthalimide 4-NH only underwent a very slight 
downfield shift (Dd = +0.05 ppm) over the titration process, 
suggesting weak or no interaction of this proton with chloride. 
A global fitting analysis assuming a 1:1 binding model was 
employed to provide the binding constant (Ka), by 
simultaneous fitting of the chemical shift changes of two 
squaramide NHs as a function of added chloride. As shown in 
Table 1, all compounds bound Cl-  with affinities ranging from 
160-520 M-1. The relative strength of anion binding (1 > 3 > 2 > 
4) correlated with the Hammett constants (sp) of their 
substituents. Much weaker binding was observed for NO3- (Ka 
<10 M-1) and stronger binding for the more basic anion H2PO4- 
(4400 M-1 determined for 4, and higher affinity of >104 M-1 
was found for more acidic compounds 1-3). Different from Cl- 
binding, the complexation of tetrahedral H2PO4-  by compound 
4 seems to involve the naphthalimide 4-NH (Dd = +1.24 ppm) 
in addition to two squaramide NHs. 
Table 1 Binding constants (M-1) for the binding of compounds 1-4 to Cl-, NO3- 
and H2PO4- (their tetrabutylammonium salts used for titrations) in DMSO-d6 at 
298 K as well as the corresponding Hammett constants (sp) of the substituents. 
Compound Kaa (Cl-) Kab (NO3-) Ka (H2PO4-) sp 
1 
2 
3 
4 
520 
240 
290 
160 
< 10 
< 10 
< 10 
< 10 
> 104c 
> 104c 
> 104c 
4400d 
0.85e 
0.54f 
0.78f 
0.00f 
a The values of binding constant (Ka) were calculated by fitting the chemical shift 
changes of two squaramide NH resonances upon addition of TBACl assuming a 
1:1 global fitting binding model. b All the proton signals were found to undergo 
negligible change in their chemical shifts during the titration process. c The 
binding constants were estimated based on the chemical shift changes of 
aromatic CH protons (adjacent to squaramide NH), due to the disappearance of 
NH signals during the titration process. d This value was determined by 
simultaneously fitting the chemical shift changes of two squaramide NHs and the 
naphthalimide 4-NH resonances upon addition of TBACl, using a 1:1 global fitting 
binding model. e The s value for 3,5-di-CF3 substitution was obtained from the pKa 
of 3,5-bis(trifluoromethyl)benzoic acid (J. Org. Chem., 2016, 81, 12116-12127). f 
Values obtained from ref. Chem. Rev., 1991, 91, 165-195. 
 
Fig. 3 Schematic illustration of the assays utilized for measuring the Cl-/NO3- antiport using the ISE (a); the H+/Cl– symport or OH–/Cl– antiport using the NMDG-Cl assay 
in the absence (b) and presence (c) of Gramicidin D (proton channel). 
The chloride-nitrate transport activities of compounds 1-4 
across lipid bilayers were evaluated using liposome-based 
techniques based on a chloride ion-selective electrode (ISE, Fig. 
3).11 Briefly, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) unilamellar vesicles (mean diameter 200 nm) were 
loaded with NaCl (489 mM, buffered to pH 7.2 with 5 mM 
sodium phosphate), and then suspended in a NaNO3 solution 
(489 mM, buffered to pH 7.2 with 5 mM sodium phosphate). 
The Cl-/NO3- transport process was initiated by the addition of 
DMSO solution of compounds 1-4 to these vesicles, and the 
resultant chloride efflux was monitored using an ISE. The Hill 
analysis12 was conducted by following chloride efflux at 
different concentrations of transporters (in mol% with respect 
to lipid concentration) to obtain EC50 value (the concentration 
of transporter needed to achieve 50% chloride efflux in 270 s) 
and Hill coefficient n (indicating the stoichiometry of the 
formed complex during the transmembrane transport 
process13). As shown in Table 2, compound 1 with two CF3 
substituents possessed the best transport activity with a 
substantially lower EC50  value (0.15 mol%) than previously 
reported naphthalimide-(thio)ureas (> 0.4 mol%).6 The anion 
transport activity of the compounds (1 > 3 > 2 > 4) followed 
the same trend as their anion binding affinities. The Hill 
coefficient values of ~1 is consistent with a  mobile carrier 
mechanism via formation of a 1:1 receptor-anion complex. 
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Fig. 4 Chloride efflux promoted by compounds 1-4 (2 mol% compound to lipid) 
from unilamellar POPC vesicles containing 489 mM NaCl buffered to pH 7.2 with 
5 mM phosphate salts, suspended in 489 mM NaNO3 buffered to pH 7.2 with 5 
mM phosphate salts. At the endpoint of each experiment (300 s), the detergent 
(Triton X-100) was added to lyse the vesicles and calibrate the electrode to 100% 
chloride efflux. Each point represents the average of three trials. Pure DMSO was 
utilized as a control experiment. 
Previous studies have shown that anion transporters could 
dissipate the pH gradient across lipid bilayer in vesicle-based 
experiments, via H+/Cl– symport or OH–/Cl– antiport 
mechanism.14 In order to explore this possibility, a series of 
assays were performed using fluorescent dye HPTS (8-
hydroxypyrene-1,3,6-trisulfonic acid) as pH indicator and N-
methyl-D-glucamine (NMDG) chloride as a chloride ion 
source.15 Briefly, POPC liposomes were firstly prepared 
containing 1 mM HPTS and 100 mM NMDG-Cl buffered to pH 
7.0, and suspended in an external solution of 100 mM NMDG-
Cl buffered to pH 7.0. Then, NMDG (5 mM) was added as a 
base pulse to create a transmembrane pH gradient (DpH = 1.0) 
and then the transporter was immediately added into the 
above suspension to trigger ion transport process and the 
resultant dissipation of pH gradient (Fig. 3b). As shown in Fig. 5, 
the H+/Cl– cotransport (or OH–/Cl– antiport) took place. To 
quantitatively evaluate the Cl–-H+/OH– transport activity of 
compounds 1-4, Hill analysis was also carried out to give the 
corresponding values of EC50 and Hill coefficient (n). From 
Table 2, the H+/Cl– cotransport (or OH–/Cl– antiport) activity of 
1-4 followed the same order as that of the Cl–/NO3– exchange. 
The presence of proton channel gramicidin D did not affect the 
rate of pH gradient dissipation of all compounds (ESI), 
suggesting that H+ or OH– transport is not rate-limiting in this 
assay (acceleration of H+ transport by gramicidin D did not 
improve the overall transport rate).15 Note that for all 
compounds the EC50 values in the ISE Cl-/NO3- exchange assay 
is about 10 times the values in the HPTS assay, which is 
consistent with the fact that the ISE assay requires a higher ion 
flux (~500 mM of Cl- and NO3-) than the HPTS assay (5 mM of 
Cl- and H+ or OH–) for the transport process to reach 
thermodynamic equilibrium.16 
 
Fig. 5 H+/Cl– symport or OH–/Cl– antiport facilitated by compounds 1-4 (0.2 mol% 
compound to lipid) from unilamellar POPC vesicles containing both 1 mM HPTS and 100 
mM NMDG-Cl buffered to pH 7.0 with 10 mM HEPES buffer and suspended in an 
external solution of 100 mM NMDG-Cl buffered to pH 7.0 with 10 mM HEPES buffer. At 
the endpoint of each experiment (200 s), the detergent was added to lyse the vesicles 
and collapse the pH gradient for calibration of HPTS fluorescence. Pure DMSO was 
utilized as a control experiment. 
Table 2. Summary of anion transport parameters (kini, EC50 and n) and calculated 
lipophilicity values (clog P) for compounds 1-4.  
Comp. kinia EC50, 270 sb 
(Cl-/NO3-) 
nc EC50, 200 sd 
(Cl–-H+/OH–) 
nc clog Pe 
1 
2 
3 
4 
1.2 
0.57 
1.0 
0.33 
0.15 
0.63 
0.26 
2.07 
0.9 
0.8 
1.0 
0.9 
0.018 
0.055 
0.041 
0.27 
1.5 
1.3 
1.4 
1.8 
5.8 
5.4 
4.9 
5.1 
a Values determined by fitting the plot of relative chloride release (y) versus 
time (x) for 2 mol% transporter to lipid to an asymptotic function y = 
a-b´cx. The initial rate of chloride release (kini in %S-1) was obtained by 
-bln(c). b Molar percentage with respect to lipid needed to obtain 50% 
chloride efflux at 270 s from the Cl-/NO3- exchange assay. c Hill coefficient 
from Hill analysis. d Molar percentage with respect to lipid needed to obtain 
50% chloride efflux at 200 s from the HPTS  assay e The log P values were 
calculated via VCCLab.  
The presence of the 1,8-naphthalimide fluorophore within 
compounds 1-4 allows them to be used for live cell imaging. 
This was explored using human lung carcinoma A549 cell line. 
Fluorescence micrographs were collected after treatment of 
the cells with compounds 1-4 (1.0 μM) for 24 hours and then 
free compound was washed away with PBS buffer. 
Interestingly, the most active transporter 1 exhibited a bright 
green fluorescence within the cytoplasm of A549 cells (Fig. 6), 
confirming its ability to fluorescently stain the cells. 
Importantly, compound 1 up to 100 μM exhibited no toxicity 
to A549 cells as determined using a CCK-8 assay (ESI). In 
comparison, compound 2 showed a poor fluorescent staining 
of A549 cells even at 10 μM. The second most active 
transporter 3 demonstrated a marginal fluorescence in A549 
cells, which became stronger with increasing concentration; 
however, a deliverability issue at 10 μM impeded its ability to 
stain cells at high concentrations, under which conditions the 
precipitation was observed. The least active transporter 4 did 
not show any detectable cell staining at all concentrations (ESI). 
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Fig. 6 Fluorescent micrographs of A549 cells after incubation with compounds 1 
(1.0 μM, left) and 3 (1.0 μM, right) for 24 hours. The bright-field and fluorescent 
images were displayed in the upper and lower row, respectively. Scale bar: 25 
µm. 
Conclusions 
A series of squaramide-based fluorescent anion receptors 
were synthesized, bearing a 1,8-naphthalimide moiety as the 
fluorophore. Their anion binding and transmembrane 
transport properties towards biologically important chloride 
ions were investigated. The results indicated that these 
compounds have moderate to relatively strong affinities 
towards Cl– in DMSO-d6, with the highest affinity of 520 M-1 
observed for the most acidic compound 1. Compounds 1-4 
facilitate chloride transport into the vesicles via Cl-/NO3- 
antiport and Cl-/H+ symport (or functionally equivalent 
Cl-/OH- antiport) mechanisms. The relative transmembrane 
transport activities of these compounds were mainly dictated 
by their chloride affinities. The most active transporter 1 was 
found to have the highest efficiency in fluorescent staining of 
living A549 cells among the squaramides while being nontoxic 
and possessing substantially higher anion transport activity 
than previously reported fluorescent anion transporters.6 
These results represent an important step forward in 
developing highly active fluorescent transmembrane anion 
transporters that are useful for studying the sub-cellular 
localization and pharmacokinetics of anion transporters in 
biological systems. 
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Squaramides functionalised with a naphthalimide fluorophore as effective fluorescent anion transporters.  
 
 
 
